VolitionRX Limited Watch

from 10-Q 12 pages Pledge Agreement

from 10-Q 17 pages Guarantor Security Agreement

from 10-Q 12 pages Pledge Agreement

from 10-Q 8 pages Guaranty (The “Guaranty”), Dated as of May 15, 2025, by Singapore Volition Pte. Limited, a Corporation Organized Under the Laws of Singapore (“Volition Singapore”), Volition Global Services Srl, a Corporation Organized Under the Laws of Belgium (“Volition Global”), Belgian Volition Srl, a Corporation Organized Under the Laws of Belgium (“Volition Belgium”), Volition Diagnostics Uk Limited, a Corporation Organized Under the Laws of Laws of England (“Volition Uk”), Volition America, Inc., a Delaware Corporation (“Volition USA”) and Volition Veterinary Diagnostics Development, LLC, a Texas Limited Liability Company (“Volition Veterinary” And, Collectively With Volition Singapore, Volition Global, Volition Belgium, Volition Uk and Volition USA, the “Guarantors” and Each, a “Guarantor”) in Favor of Lind Global Asset Management XII LLC (The “Lender”)

from 10-Q 16 pages Security Agreement

from 10-Q 13 pages VolitionRX Limited Common Stock Purchase Warrant

from 10-Q 21 pages VolitionRX Limited Form of Senior Secured Convertible Promissory Note Due May [•], 2027

from 10-Q 44 pages Securities Purchase Agreement

from 10-K 6 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It (I) Is Not Material and Would Be Competitively Harmful if Publicly Disclosed, or (II) Contains Personally Identifiable Information, Omitted Pursuant to Item 601(a)(6) Under Regulation S-K. Independent Director Agreement

from 8-K 32 pages Securities Purchase Agreement

from 8-K 32 pages Securities Purchase Agreement

from 10-Q 2 pages (1) Volition Global Services Srl, a Company Incorporated Under the Laws of Belgium With Company Number Be0773412276 Whose Principal Office Is at 22 Rue Phocas Lejeune, Parc Scientifique, 5032, Isnes, Belgium (The “Company”); and (2) 3f Management Sprl, a Company Located at [***] (The “Consultant”) (Referred to Herein Individually as a “Party” or Collectively as the “Parties”) Recitals (A) Whereas, This First Amendment Is Supplemental to the Consulting Services Agreement Between the Parties Dated September 15, 2021 (The “Agreement”); (B) Whereas, the Parties Hereto Desire by This First Amendment to Amend the Terms of the Agreement. Now, Therefore, for and in Consideration of the Covenants Set Forth Herein, the Parties Agree That the Agreement Is Hereby Amended as Follows

from 10-Q 9 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It (I) Is Not Material and Would Be Competitively Harmful if Publicly Disclosed, or (II) Contains Personally Identifiable Information, Omitted Pursuant to Item 601(a)(6) Under Regulation S-K. Permanent Employment Contract

from 8-K 40 pages Securities Purchase Agreement

from 8-K 14 pages VolitionRX Limited 2024 Stock Incentive Plan as Adopted by the Board of Directors on April 24, 2024 Article 1 Purposes of the Plan

from 10-K 14 pages Dated: March 19, 2024 Contract of Employment Between Volition Diagnostics Uk Ltd and Dr Andrew Retter

from 8-K 14 pages VolitionRX Limited 2015 Stock Incentive Plan as Amended April 17, 2023 Article 1 Purposes of the Plan

from 10-K 7 pages Singapore Volition Pte. Limited Employment Agreement Group Chief Executive Officer

from 8-K 16 pages VolitionRX Limited 2015 Stock Incentive Plan as Amended April 4, 2022 Article 1 Purposes of the Plan

from 10-Q 35 pages Master License and Product Supply Agreement